Correction: iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering
iSpecimen Inc . (Nasdaq: ISPC) ('iSpecimen' or the 'Company'), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced on July 25, 2025 the closing of its previously announced underwritten public offering of 5,714,283 shares of its common stock (or pre-funded warrants to purchase common stock in lieu thereof) at a public offering price of $0.70 per share (the 'Offering'). The aggregate gross proceeds to the Company from the Offering was approximately $4 million, before deducting underwriting discounts and commissions and other offering expenses.
The Company intends to use the net proceeds from the Offering to pay $1,500,000 for marketing and advertising services to be provided by IR Agency LLC, $1,000,000 to fund the initial milestone payment under a definitive agreement with Sales Stack Solutions Corp., and the remainder for working capital and general corporate purposes.
The Offering was conducted on a firm commitment basis. WestPark Capital, Inc. acted as the Sole Book-Runner in connection with the Offering.
The securities described above are being offered pursuant to a registration statement on Form S-1 (File No. 333-286958), which was declared effective by the Securities and Exchange Commission (the 'SEC') on July 23, 2025. The Offering is being made only by means of a written prospectus that forms a part of the registration statement. A final prospectus relating to the Offering has been filed with the SEC. Copies of the final prospectus relating to the Offering may be obtained from WestPark Capital, Inc., 1800 Century Park East, Suite 220, Los Angeles, CA 90077, tel: 310-203-2919, e-mail: [email protected] and are available on the SEC's website.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.
About iSpecimen
iSpecimen (Nasdaq: ISPC) offers an online marketplace for human biospecimens, connecting scientists in commercial and non-profit organizations with healthcare providers that have access to patients and specimens needed for medical discovery. Proprietary, cloud-based technology enables scientists to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers and other healthcare organizations. For more information, please visit www.ispecimen.com .
Safe Harbor Statement
Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute 'forward-looking statements.' These statements include, but are not limited to, statements concerning the development of our company. The words 'anticipate,' 'believe,' 'continue,' 'could,' 'estimate,' 'expect,' 'intend,' 'may,' 'plan,' 'potential,' 'predict,' 'project,' 'should,' 'target,' 'will,' 'would' and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The reader is cautioned not to rely on such forward-looking statements. Such forward-looking statements relate to future events or our future performance. In evaluating these forward-looking statements, you should consider various factors, including the uncertainty regarding future commercial success; risks and uncertainties associated with market conditions and the Company's ability to satisfy the closing conditions related to the Offering. These and other factors may cause our actual results to differ materially from any forward-looking statements. Forward-looking statements are only predictions and actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including factors discussed in the 'Risk Factors' section of the Company's Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on April 14, 2025, as well as other SEC filings. Any forward-looking statements contained in this press release speak only as of the date hereof and, except as required by federal securities laws, iSpecimen specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.
[email protected]
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Ahmedabad Plane Crash
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 minutes ago
- Yahoo
Trump gets tariffs; Americans get price hikes
By David Gaffen and Marleen Kaesebier (Reuters) -U.S. President Donald Trump is getting his tariffs. Companies are making it clear how they intend to deal with it - passing them on to American consumers. Throughout the spring, big retailers and consumer product makers warned that levies on imported goods would squeeze their operations, forcing them to choose between lower earnings and passing on higher costs to customers. In the case of Procter & Gamble and others, it is both of those things. On Tuesday, the packaging giant, which makes household basics spanning from Bounty paper towel to Tide detergent, issued a sour outlook for 2025 and sent a message to big retailers like Walmart that it would have to raise prices on some U.S. goods from next week. This challenge facing companies in coming quarters will likely feed through to everyday consumers. P&G said it would raise prices on about a quarter of its products in the U.S. to help offset the cost of new tariffs. Price hikes are in the mid-single digits across categories, a spokesperson for the company said. While U.S. stock indexes have soared to record highs this year, built on massive investment in technology shares, many consumer bellwethers have struggled. Since Trump's April 2 "Liberation Day" tariff announcements, P&G shares have declined 19%; Nestle is down 20%; Kimberly-Clark has lost 11%, and PepsiCo is off nearly 7%, while the benchmark S&P 500 stock index has gained more than 13%. Consumer goods, food and drink companies have struggled with lackluster sales since the pandemic, as shoppers have balked at increasingly expensive name-brand packaged food. Nestle said last week that consumers in North America remained wary of paying more at the cash register. More price hikes will deepen investor worries about how big brands are navigating the combined challenge of thrifty consumers and hefty costs created by Trump's trade war. "You're going to see companies like Walmart, Amazon, and Best Buy forced to pass price increases to consumers," said Bill George, former chairman and CEO of Medtronic and executive education fellow at Harvard Business School. "Main Street has yet to see the fallout from increased tariffs - and they're going to go higher." Between July 16 and 25, companies in the Reuters global tariff tracker said they expected to lose a combined $7.1 billion to $8.3 billion for the full year. GM, Ford and other carmakers have absorbed the cost of tariffs - totaling billions of dollars - so far. Many companies shipped more goods and raw materials into the U.S. before tariffs hit. Economists and analysts reckon that hoarding has helped some delay hiking prices until later in the year and explains why tariffs have not yet shown up in U.S. inflation data. Andrew Wilson, International Chamber of Commerce deputy secretary general, estimates inflation will be felt once companies have run down inventory, but that might not be until the fourth quarter or first quarter of next year. Others like Ray Ban-maker EssilorLuxottica have already hiked prices. Swiss watch and jewelry maker Swatch increased prices by about 5% after Trump announced tariffs in April with "zero impact" on sales, CEO Nick Hayek told Reuters recently. High-end brands like Tissot watches are less price sensitive to increases. Customers wanting to splash out on an expensive watch might also buy abroad when travelling where taxes are lower, he said. "You cannot do this with cars. You cannot do this with machines. But you can do this with watches. So it's not so problematic for us," he said. Sign in to access your portfolio
CNBC
17 minutes ago
- CNBC
Is Palo Alto joining the M&A party? Plus, the S&P 500 hits an earnings bump
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Market update: Stocks are slightly weaker, with the S & P 500 on track for its first negative session since July 18. Earnings could be the culprit, with negative reactions outweighing the positives. The bigger test comes later in the week when we get the quarters and commentary from several megacap tech stocks including Microsoft , Meta Platforms , Amazon , and Apple . More deals : Several multi-billion-dollar deals have been announced over the past week, spanning industries from banking and railroads to energy. Now it appears cybersecurity may be joining the party. Shares of Palo Alto Networks dipped after The Wall Street Journal reported the cybersecurity company was in talks to acquire identity management company CyberArk Software in a deal that could value it at more than $20 billion. Representatives from both companies declined to comment when reached by on Tuesday. It's not the first talk of a deal this month involving Palo Alto: The company was previously reported to be interested in buying SentinelOne , although that story was quickly denied by Palo Alto. We'll have to see where this one goes, but strategically the deal makes sense since it would boost Palo Alto's presence in the increasingly important identity and access management market. Palo Alto shares fell on the news as investors braced for this hefty price target and risks associated with large scale M & A. But one could argue that this deregulatory administration makes it a good time to make a big deal. Up next: Starbucks reports its latest earnings after the closing bell, along with Visa , Booking Holdings , PPG , Republic Services , and Seagate . Before the bell on Wednesday, Vertiv , GE Healthcare , Altria , Kraft Heinz , Generac , Humana , Hershey , and VF Corp deliver results. Data releases include mortgage applications, ADP employment, and the advanced read on second quarter GDP. Wednesday is also Fed day, with the FOMC rate announcement set for 2 p.m. ET. With interest rates expected to stay unchanged, investors will listen closely to Chairman Jerome Powell's remarks for clues to the central bank's next move in September. (See here for a full list of the stocks in Jim Cramer's Charitable Trust.) As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio. If Jim has talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB. NO SPECIFIC OUTCOME OR PROFIT IS GUARANTEED.
Yahoo
34 minutes ago
- Yahoo
How is the Dow calculated? Here's a breakdown.
The Dow Jones Industrial Average (DJI) is an index comprised of 30 stocks. Because of its structure, it doesn't always trade in sync with other indexes like the S&P 500 (GSPC) and Nasdaq Composite (IXIC). In the video above, Stocks in Translation Host Jared Blikre explains how the Dow works. To watch more expert insights and analysis on the latest market action, check out more Stocks in Translation here. Today in Stocks and Translation, we're gonna take a look at how the Dow is actually calculated. Now, the Dow was born all the way back in 1896, nearly 130 years ago, before computers, before calculators, so this index of 30 stocks had to be easy to calculate. And for sake of simplicity, only the stock prices used. So the higher the stock price, the greater the weight in the index. And almost every other index, by the way, like the S&P and the Nasdaq, they use a company's market capitalization, but that gives that requires a lot more paperwork and more calculations. So here's the full method. Basically, you sum the prices of all 30 stocks in the index, and then you divide it by a number called the Dow divisor, which corrects for splits and changes in the components of the stocks. So anytime a stock has a stock split in the index, or when one stock is swapped out for another one, that Dow divisor will change. Now, here is a list of the four top stocks by price. Goldman Sachs is right at the top, with $723.65 as of the close yesterday. Microsoft is number two, Caterpillar is number three, Home Depot is number four. Now, United Health has a stock price of about $267 today, but before, uh, just a few months ago, it topped out at about 600, so it actually would have been number two in this list, had it not seen such a big slide. And I went in, and I calculated what the Dow would look like with different configurations here. So the orange line right here, which terminates last, that is the actual Dow. And then when you take out United Health in ye yellow, you have that line up here. And then I also took out Salesforce, Merck, and then Apple, because those were some of the biggest losers this year by percentage terms. And what you end up with is is a material materially higher Dow price without these big drags in it. And some of them can be actually quite big. And I also did another calculation here. I took, uh, the Dow price-weighted, that's the normal price weighting in white here, and then I also calculated it by market cap, starting at the beginning of the year. And when you do it by market cap, and I'm just gonna kind of trace this out here, we actually saw a lot more volatility by the lows. And again, this just includes all 30 stocks. I'm not taking out United Health or any of them. I'm just doing a different alternate calculation. So more volatility with the market cap weight, uh, version that we saw this year. Now, to sum up all the results, here's the market cap weighted 2025 year-to-date return. That came in at 7.3%. The actual price weighted number that everybody uses is 5.4%, and then the Dow minus United Health, that came in all the way up to 9.3%. And then you can take out Salesforce and Merck, and the numbers keep going up, and by the time you take out Apple, you have a Dow that's up 12.4%, and that's more than double the actual return of 5% and change. So something to think about here, uh, there's no guarantee that the Dow will always be calculated like this, but after 130 years, maybe they're just not gonna change. Tune into Stocks and Translation podcast for more jargon-busting deep dives. New episodes can be found every Tuesday and Thursday on Yahoo Finance's website, or wherever you find your podcasts. Related Videos Fed meeting: Why holding rates steady would be the 'right call' Market is seeing 'pockets of speculation,' not 'excessive' froth Berkshire trims VeriSign stake, Novo Nordisk craters, PayPal falls Market's 'fuel' for further P/E expansion is 'nearing empty' Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
